Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
The products are far from a proven sleep treatment.
High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
A new University of Georgia network meta-analysis finds tirzepatide sitting at the top of the weight-loss heap among commonly ...
Murder suspect brain scans published Monday in Aggression and Violent Behavior reveal that killers who planned their crimes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results